BRISTOL-MYERS SQUIBB CO (BRM.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BRM - US1101221083 - Common Stock
48.28 EUR
+0.11 (+0.22%)
Taking everything into account, BRM scores 6 out of 10 in our fundamental rating. BRM was compared to 54 industry peers in the Pharmaceuticals industry. BRM has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on BRM. Finally BRM also has an excellent dividend rating. These ratings could make BRM a good candidate for value and dividend investing.
1. Profitability
1.1 Basic Checks
- BRM had positive earnings in the past year.
- In the past year BRM had a positive cash flow from operations.
- In multiple years BRM reported negative net income over the last 5 years.
- In the past 5 years BRM always reported a positive cash flow from operatings.
1.2 Ratios
- BRM has a Return On Assets (6.23%) which is in line with its industry peers.
- BRM's Return On Equity of 32.55% is amongst the best of the industry. BRM outperforms 81.13% of its industry peers.
- BRM has a Return On Invested Capital of 16.42%. This is in the better half of the industry: BRM outperforms 77.36% of its industry peers.
- BRM had an Average Return On Invested Capital over the past 3 years of 10.96%. This is below the industry average of 13.93%.
- The last Return On Invested Capital (16.42%) for BRM is above the 3 year average (10.96%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROIC | 16.42% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)10.96%
ROIC(5y)9.23%
1.3 Margins
- BRM's Profit Margin of 12.57% is in line compared to the rest of the industry. BRM outperforms 50.94% of its industry peers.
- BRM has a Operating Margin of 33.51%. This is amongst the best in the industry. BRM outperforms 83.02% of its industry peers.
- BRM's Operating Margin has declined in the last couple of years.
- BRM has a Gross Margin of 73.15%. This is in the better half of the industry: BRM outperforms 60.38% of its industry peers.
- BRM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% |
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRM is creating value.
- BRM has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, BRM has less shares outstanding
- BRM has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.26 indicates that BRM is not a great score, but indicates only limited risk for bankruptcy at the moment.
- BRM's Altman-Z score of 2.26 is in line compared to the rest of the industry. BRM outperforms 47.17% of its industry peers.
- BRM has a debt to FCF ratio of 3.20. This is a good value and a sign of high solvency as BRM would need 3.20 years to pay back of all of its debts.
- BRM has a Debt to FCF ratio of 3.20. This is in the better half of the industry: BRM outperforms 66.04% of its industry peers.
- BRM has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
- BRM's Debt to Equity ratio of 2.41 is on the low side compared to the rest of the industry. BRM is outperformed by 81.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Altman-Z | 2.26 |
ROIC/WACC1.94
WACC8.46%
2.3 Liquidity
- BRM has a Current Ratio of 1.27. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of BRM (1.27) is comparable to the rest of the industry.
- A Quick Ratio of 1.17 indicates that BRM should not have too much problems paying its short term obligations.
- The Quick ratio of BRM (1.17) is better than 67.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 460.68% over the past year.
- Measured over the past years, BRM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.57% on average per year.
- The Revenue has been growing slightly by 1.26% in the past year.
- Measured over the past years, BRM shows a quite strong growth in Revenue. The Revenue has been growing by 13.06% on average per year.
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
3.2 Future
- BRM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.29% yearly.
- Based on estimates for the next years, BRM will show a decrease in Revenue. The Revenue will decrease by -5.06% on average per year.
EPS Next Y478.44%
EPS Next 2Y130.59%
EPS Next 3Y73.3%
EPS Next 5Y35.29%
Revenue Next Year0.23%
Revenue Next 2Y-3.95%
Revenue Next 3Y-3.2%
Revenue Next 5Y-5.06%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 8.55, the valuation of BRM can be described as very reasonable.
- Compared to the rest of the industry, the Price/Earnings ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 90.57% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of BRM to the average of the S&P500 Index (27.38), we can say BRM is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 9.25, the valuation of BRM can be described as reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 88.68% of the companies listed in the same industry.
- BRM is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.55 | ||
| Fwd PE | 9.25 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BRM is valued cheaper than 90.57% of the companies in the same industry.
- 100.00% of the companies in the same industry are more expensive than BRM, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.46 | ||
| EV/EBITDA | 6.93 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- BRM has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as BRM's earnings are expected to grow with 73.30% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y130.59%
EPS Next 3Y73.3%
5. Dividend
5.1 Amount
- BRM has a Yearly Dividend Yield of 4.45%, which is a nice return.
- BRM's Dividend Yield is rather good when compared to the industry average which is at 1.59. BRM pays more dividend than 92.45% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.85, BRM pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.45% |
5.2 History
- On average, the dividend of BRM grows each year by 11.67%, which is quite nice.
Dividend Growth(5Y)11.67%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- 82.81% of the earnings are spent on dividend by BRM. This is not a sustainable payout ratio.
- The dividend of BRM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP82.81%
EPS Next 2Y130.59%
EPS Next 3Y73.3%
FRA:BRM (1/16/2026, 7:00:00 PM)
48.28
+0.11 (+0.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-05 2026-02-05/amc
Inst Owners81.87%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap98.29B
Revenue(TTM)48.03B
Net Income(TTM)6.04B
Analysts70
Price Target48.75 (0.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.45% |
Yearly Dividend2.08
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)6.26%
PT rev (3m)10.2%
EPS NQ rev (1m)-2.77%
EPS NQ rev (3m)1.7%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)1.81%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)1.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.55 | ||
| Fwd PE | 9.25 | ||
| P/S | 2.38 | ||
| P/FCF | 7.46 | ||
| P/OCF | 6.87 | ||
| P/B | 6.15 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.93 |
EPS(TTM)5.65
EY11.7%
EPS(NY)5.22
Fwd EY10.81%
FCF(TTM)6.47
FCFY13.4%
OCF(TTM)7.03
OCFY14.56%
SpS20.31
BVpS7.84
TBVpS-10
PEG (NY)0.02
PEG (5Y)N/A
Graham Number31.58
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROCE | 23.41% | ||
| ROIC | 16.42% | ||
| ROICexc | 21.58% | ||
| ROICexgc | 109.99% | ||
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% | ||
| FCFM | 31.86% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)10.96%
ROIC(5y)9.23%
ROICexc(3y)12.89%
ROICexc(5y)10.99%
ROICexgc(3y)70.36%
ROICexgc(5y)72.03%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Debt/EBITDA | 2.13 | ||
| Cap/Depr | 26.84% | ||
| Cap/Sales | 2.75% | ||
| Interest Coverage | 7.66 | ||
| Cash Conversion | 79.11% | ||
| Profit Quality | 253.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.26 |
F-Score6
WACC8.46%
ROIC/WACC1.94
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
EPS Next Y478.44%
EPS Next 2Y130.59%
EPS Next 3Y73.3%
EPS Next 5Y35.29%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
Revenue Next Year0.23%
Revenue Next 2Y-3.95%
Revenue Next 3Y-3.2%
Revenue Next 5Y-5.06%
EBIT growth 1Y44.7%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year263.97%
EBIT Next 3Y49.92%
EBIT Next 5Y23.19%
FCF growth 1Y30.91%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y28.71%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%
BRISTOL-MYERS SQUIBB CO / BRM.DE FAQ
What is the fundamental rating for BRM stock?
ChartMill assigns a fundamental rating of 6 / 10 to BRM.DE.
What is the valuation status of BRISTOL-MYERS SQUIBB CO (BRM.DE) stock?
ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (BRM.DE). This can be considered as Undervalued.
How profitable is BRISTOL-MYERS SQUIBB CO (BRM.DE) stock?
BRISTOL-MYERS SQUIBB CO (BRM.DE) has a profitability rating of 6 / 10.
What is the expected EPS growth for BRISTOL-MYERS SQUIBB CO (BRM.DE) stock?
The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BRM.DE) is expected to grow by 478.44% in the next year.
Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?
The dividend rating of BRISTOL-MYERS SQUIBB CO (BRM.DE) is 8 / 10 and the dividend payout ratio is 82.81%.